Additionally, an association between impaired Leydig cell function and testicular cancer has been indicated by identification of increased LH levels and generally low testosterone levels in men with testicular carcinoma in situ (precursor cells of testicular cancer) when compared to men without CIS of the testis[35]. Here, PLOD1 is linked to testicular cancer.